You’re About to See the Real AI Winners Stand Up

Episode Overview

• The Purpose-Driven Asset Management Model: This episode explores how American Century Investments operates under a unique corporate structure where over 40% of its dividends fund the Stowers Institute for Medical Research, aligning financial performance directly with life-saving scientific discovery.
• The Evolution of Asset Management and Distribution: The discussion maps the structural industry shifts from the direct-to-consumer mutual fund era of the 1980s and 1990s, to the advisor-centric model of the 2000s, and finally to the emerging platform- and AI-driven era of today.
• Active ETFs and the Rise of Systematic Alpha: Leaders explain how modern investment brands like Avantis break the active/passive dichotomy by delivering low-cost, highly diversified, factor-based strategies inside the tax-efficient ETF vehicle.
• The AI Adoption Curve and Market Resiliency: The conversation analyzes whether current market valuations represent a speculative "earnings bubble" or a structural transition where early tech "creators" hand off market leadership to industries adopting AI for operational efficiency.
• Innovative Paradigms in Medical Research: The episode details how the Stowers Institute utilizes evolutionary biology (studying healthy, disease-resistant organisms rather than human pathology) and open-science failures to accelerate global drug discovery.

Key Concepts

• Purpose-Driven Corporate Governance: By funneling over 40% of corporate dividends to basic medical research, American Century Investments creates a self-sustaining funding engine. This structure aligns the fiduciary duties of asset management with global philanthropy, serving as a powerful motivator for employees and clients alike.
• The Platform Era of Distribution: Control of the client relationship is shifting away from individual financial advisors and toward consolidated technological gates, such as massive retirement platforms, model marketplaces, and AI-driven financial assistants.
• Systematic Active Investing (The Avantis Model): This hybrid approach combines the low cost, tax efficiency, and broad diversification of indexing with systematic factor tilts (such as value and profitability). It aims to deliver benchmark-beating returns for only a minor fee premium over passive funds, minimizing the "fee drag" that historically hindered active managers.
• The AI "Cake" Architecture: The AI landscape consists of five layers: physical infrastructure (power, cooling), chips (semiconductors), data centers, foundational models (LLMs), and applications. Capital requirements decrease as you move up the stack, with the highest potential profit margins sitting at the application layer.
• The Creator-to-Adopter Hand-off: Early stock market gains from AI were concentrated in the "creators" (chipmakers and model builders). The next phase of economic growth will be captured by "adopters" (traditional companies in healthcare, finance, and industrials) using AI to optimize workflows and expand operating margins.
• Evolutionary Medicine and Open-Science Failures: Traditional medicine focuses on human biological failures. In contrast, studying organisms that successfully evolved to resist diseases (e.g., animals that avoid diabetes or osteoporosis) offers a unique path to human therapies. Additionally, publishing scientific failures prevents global researchers from wasting capital on unviable hypotheses.

Quotes

• At 0:10:15 - "We are purpose-driven... over 40% of our dividends each and every year go to the Stowers Institute for Medical Research... It provides a level of inspiration to our employees that’s almost hard to articulate." - Explaining the impact of their unique philanthropic ownership structure.
• At 0:14:14 - "When you're in a Chief Operating Officer role, you are making all sorts of trade-offs between talent, technology, regulation, capital allocations, etc... and those trade-offs are actually exactly what a CEO does." - Describing how a background in operations and risk management prepares a leader for executive leadership.
• At 0:25:08 - "Avantis kind of splits the difference between active and passive investing. They are low-cost, highly diversified building blocks that give people the opportunity to outperform the benchmark." - Detailing the value proposition of systematically active, factor-based ETFs.
• At 0:26:05 - "Schwab was the first one to offer free ETF trading... and that was a gigantic tailwind for the business." - Highlighting how the elimination of brokerage commissions accelerated advisor adoption of ETFs.
• At 0:27:57 - "We use the same exact investment philosophy across every single asset class. So if you like a particular product... you're going to like the other ones as well." - Explaining why maintaining a consistent philosophy across products builds trust and simplifies portfolio construction for advisors.
• At 0:28:46 - "Everybody bought the hot ones, and that resulted in a portfolio from an asset manager's perspective where your client has one product. Under Avantis... when people buy us, they tend to buy three or four positions." - Contrasting traditional "star manager" chasing with a diversified, holistic allocation strategy.
• At 0:30:57 - "There was a philosophy out there that portfolio managers who are managing active funds really cared about secrecy... That ended up not being true... All these active ETFs for the most part are not hiding what they traded." - Clarifying why fears of front-running in transparent active ETFs proved to be overblown.
• At 0:34:43 - "When funds get too big, in order to continue to generate alpha, they have to get closed. The ETFs, we've built them so that they can scale perpetually." - Outlining the scalability advantages of diversified ETFs over capacity-constrained active mutual funds.
• At 0:37:29 - "It's less about predicting and more about relying on what we call financial science and academically driven research that drives the portfolios." - Defining the systematic, empirical approach of factor investing over macro forecasting.
• At 0:54:56 - "The companies are over-earning relative to what happens when this capex normalizes." - Describing the market's primary concern regarding a potential capex bubble in artificial intelligence.
• At 1:01:21 - "Sitting on top of all of that is the app level where the actual value is created... down on the bottom of the cake requires massive investment, tons of capital. As you go up, it requires less and less capital." - Breaking down the capital structures and margin profiles of the five-layer AI architecture.
• At 1:03:00 - "Healthcare and financials, arguably, have companies that could be among the biggest beneficiaries of AI as users... as adopters." - Identifying the sectors positioned to gain the most from integrating AI into their operations.
• At 1:13:31 - "For the most part, we focus on organisms that have evolved over millions of years that should have some sort of ailment... and we focus on the animals that have avoided that." - Illustrating a paradigm shift in medical research from studying disease pathology to studying evolutionary success.
• At 1:17:21 - "I think there might be a very, very early signs of yet another pivot taking place, and that is a pivot to platforms... retirement platforms, or AI-assisted financial assistants... now platforms are owning those relationships." - Projecting the next major evolutionary phase in financial services distribution.

Takeaways

• Evaluate Corporate Structure in Partnerships: Consider partnering with or investing through organizations that have structural philanthropic ties, as these models can align long-term employee incentives and brand loyalty with broader societal benefits.
• Implement Systematically Active ETFs: Transition away from expensive, concentrated active mutual funds and zero-edge passive funds toward low-cost, highly diversified active ETFs that use systematic factor tilts (like value and profitability) to generate alpha.
• Focus on Platform Integration: Asset managers should pivot their distribution and product design away from direct-to-consumer and individual advisor marketing, focusing instead on integration within model marketplaces and automated retirement platforms.
• Look for Real Earnings Over Multiple Expansion: When assessing high-growth tech sectors, verify if stock appreciation is driven by actual earnings growth (compressing forward P/E ratios) or purely speculative valuation expansion.
• Position Portfolios for AI Adopters: Shift investment focus up the AI value chain away from high-capex hardware "creators" and toward sector "adopters" (such as healthcare, industrial, and financial companies) that can use AI tools to expand profit margins.
• Utilize Scalable Investment Vehicles: For capacity-sensitive asset classes like small-cap value, favor systematically active ETFs over traditional mutual funds to avoid liquidity bottlenecks and prevent premature fund closures.
• Apply "Open Science" Principles to Business: Share internal operational failures and negative project results within your industry to prevent the waste of collective capital and accelerate industry-wide progress.
• Fund Long-Tail Foundational Research: Recognize that commercial pharmaceutical companies require short-term pipelines, leaving a critical funding gap for basic biological research that non-profit institutes must fill to uncover future medical breakthroughs.